Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000420034 | SCV000522394 | likely benign | not specified | 2016-08-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000771773 | SCV000904448 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002062498 | SCV002486216 | likely benign | Ataxia-telangiectasia syndrome | 2023-10-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000771773 | SCV004849076 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-05-13 | criteria provided, single submitter | clinical testing | The c.2377-19T>G intronic alteration consists of a T to G substitution 19 nucleotides before coding exon 15 in the ATM gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |